Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA

Contributed by: PR Newswire

Tags

Guangzhou-Fermion

More Like This

Fermion's TYK2 JH2 Inhibitor FZ007-119 Granted IND Approval by China NMPA

Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain

Oblique Therapeutics announces that NaV 1.8 project is advancing to next stage

Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain

Pain Cloud® Launch: A Collaboration between EptivA and Infopoly Ltd., creating an advanced solution to Pain Research

Neuraptive Therapeutics Inc. Receives Orphan Drug Designation for its Lead Development Asset

PR Newswire associated0

Monument Therapeutics Announces Grant of UK Patent for Neuroinflammation Compound MT1980